ABBV vs. XAR
ABBV (AbbVie Inc.) is a stock, while XAR (SPDR S&P Aerospace & Defense ETF) is Aerospace & Defense fund tracking the S&P Aerospace & Defense Select Industry Index. Over the past 10 years, ABBV returned 19.10%/yr vs 18.45%/yr for XAR. At a 0.26 correlation, their price movements are largely independent.
Performance
ABBV vs. XAR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABBV achieves a 1.30% return, which is significantly lower than XAR's 16.10% return. Both investments have delivered pretty close results over the past 10 years, with ABBV having a 19.10% annualized return and XAR not far behind at 18.45%.
ABBV
- 1D
- 1.32%
- 1M
- 8.05%
- YTD
- 1.30%
- 6M
- 3.65%
- 1Y
- 23.06%
- 3Y*
- 22.39%
- 5Y*
- 18.94%
- 10Y*
- 19.10%
XAR
- 1D
- -1.55%
- 1M
- 3.18%
- YTD
- 16.10%
- 6M
- 18.39%
- 1Y
- 42.07%
- 3Y*
- 33.32%
- 5Y*
- 16.58%
- 10Y*
- 18.45%
ABBV vs. XAR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 1.30% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
XAR SPDR S&P Aerospace & Defense ETF | 16.10% | 46.15% | 23.32% | 23.79% | -5.02% | 2.31% | 6.18% | 39.33% | -4.58% | 33.00% |
Correlation
The correlation between ABBV and XAR is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013 | 0.26 |
Over the past year, the correlation between ABBV and XAR has dropped to 0.02 - well below their long-term average of 0.26, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABBV vs. XAR — Risk / Return Rank
ABBV
XAR
ABBV vs. XAR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and SPDR S&P Aerospace & Defense ETF (XAR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ABBV | XAR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.58 | ||
| Sortino ratioReturn per unit of downside risk | -0.78 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.25 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | 1.29 | 2.43 | -1.14 |
| Martin ratioReturn relative to average drawdown | 2.88 | 6.81 | -3.94 |
Loading charts...
Drawdowns
ABBV vs. XAR - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, roughly equal to the maximum XAR drawdown of -46.37%. Use the drawdown chart below to compare losses from any high point for ABBV and XAR.
Loading charts...
Drawdown Indicators
| ABBV | XAR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.09% | -46.37% | +1.28% |
Max Drawdown (1Y)Largest decline over 1 year | -17.32% | -17.22% | -0.10% |
Max Drawdown (3Y)Largest decline over 3 years | -20.74% | -19.73% | -1.01% |
Max Drawdown (5Y)Largest decline over 5 years | -21.92% | -32.40% | +10.48% |
Max Drawdown (10Y)Largest decline over 10 years | -45.09% | -46.37% | +1.28% |
Current DrawdownCurrent decline from peak | -4.60% | -4.32% | -0.28% |
Average DrawdownAverage peak-to-trough decline | -10.71% | -6.78% | -3.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.75% | 6.13% | +1.62% |
Volatility
ABBV vs. XAR - Volatility Comparison
The current volatility for AbbVie Inc. (ABBV) is 6.10%, while SPDR S&P Aerospace & Defense ETF (XAR) has a volatility of 11.46%. This indicates that ABBV experiences smaller price fluctuations and is considered to be less risky than XAR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABBV | XAR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.10% | 11.46% | -5.36% |
Volatility (6M)Calculated over the trailing 6-month period | 17.85% | 23.56% | -5.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.31% | 27.85% | -3.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.89% | 23.66% | -0.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.73% | 24.74% | +0.99% |
Dividends
ABBV vs. XAR - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 2.96%, more than XAR's 0.31% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.96% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
XAR SPDR S&P Aerospace & Defense ETF | 0.31% | 0.40% | 0.66% | 0.54% | 0.50% | 0.83% | 0.63% | 0.75% | 1.19% | 0.76% | 1.09% | 2.31% |
Frequently Asked Questions
ABBV and XAR have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XAR has higher volatility (11.46%) compared to ABBV (6.10%). In terms of maximum drawdown, ABBV dropped -45.09% vs XAR's -46.37%.
XAR currently has the higher Sharpe Ratio (1.50 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABBV and XAR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer